Tag: OpenLabel
Pharnext Announces Enrollment of the First Patient in the Open-Label Extension of the Pivotal Phase III Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial
Pharnext Announces Enrollment of the First Patient in the Open-Label Extension of the Pivotal Phase III Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial PARIS, France, September…